[go: up one dir, main page]

US20020081743A1 - Image analysis of urine - Google Patents

Image analysis of urine Download PDF

Info

Publication number
US20020081743A1
US20020081743A1 US10/027,522 US2752201A US2002081743A1 US 20020081743 A1 US20020081743 A1 US 20020081743A1 US 2752201 A US2752201 A US 2752201A US 2002081743 A1 US2002081743 A1 US 2002081743A1
Authority
US
United States
Prior art keywords
subject
urine
propensity
indicating
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/027,522
Inventor
Dan Gottlieb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/027,522 priority Critical patent/US20020081743A1/en
Publication of US20020081743A1 publication Critical patent/US20020081743A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Definitions

  • the present invention relates to determination of the propensity of a subject to formation of urinary stones.
  • Prophylactic treatment is known for preventing the occurrence of urinary stones. What is lacking is an efficient and cost-effective technique for screening the population in order to indicate those persons requiring prophylactic treatment.
  • the present invention seeks to provide an efficient and cost-effective technique and system for indicating the propensity of a subject to formation of urinary stones.
  • apparatus for indicating the propensity of a subject to formation of urinary stones including apparatus for optically observing a urine sample from a subject under magnification and an image analyzer operative to determine the existence of crystalline bodies in said urine sample and to provide an output indication thereof.
  • apparatus for analyzing urine of a subject including:
  • an image analyzer operative to determine the existence of bodies in the urine sample and to provide an output indication thereof.
  • the bodies may include at least one of cells, crystalline bodies, microorganisms and casts.
  • the image analyzer is also operative to provide an indication of the size of the crystalline bodies.
  • the apparatus for optically observing is operative to observe at least one urine sample in the presence of at least one reagent.
  • the apparatus for optically observing a urine sample is operative to observe a plurality of urine samples from a subject in the presence of a plurality of different reagents.
  • the plurality of different reagents comprise crystallization inducers of different activities.
  • the plurality of different reagents comprise crystallization inducers of different concentrations.
  • the at least one reagent comprises a crystallization inducer.
  • the image analyzer includes software which measures the mass of the bodies.
  • the image analyzer includes software which indicates the shape of the bodies.
  • the image analyzer includes software which indicates changes in the bodies over time.
  • FIG. 1 is a simplified pictorial illustration of a system and method for analyzing urine of a subject which is particularly useful for indicating the propensity of a subject to formation of urinary stones in accordance with a preferred embodiment of the present invention
  • FIG. 2 is an illustration of a typical image analysis report provided by the system and method of FIG. 1;
  • FIG. 3 is a simplified flowchart illustrating principal functional features of image analysis performed by the system and method of FIG. 1;
  • FIGS. 4, 5, and 6 are each simplified flowcharts illustrating constituents of the functional features of the flowchart of FIG. 3.
  • Appendix A is a hexadecimal dump of software employed in accordance with a preferred embodiment of the present invention.
  • FIGS. 1 and 3 are respectively a simplified pictorial illustration and a flow chart of a system and method for analyzing urine of a subject which is particularly useful for indicating the propensity of a subject to formation of urinary stones in accordance with a preferred embodiment of the present invention.
  • the present invention seeks to provide an efficient and cost-effective technique and system for indicating the propensity of a subject to formation of urinary stones.
  • a sample of urine 10 received from a subject is centrifuged in a centrifuge 11 and thereafter preferably added dropwise to a plurality of containers 12 , here numbered 1 - 5 , each containing a reagent which enhances crystallization of calcium oxalate salts in the urine.
  • the reagent comprises natrium-oxalate in different concentrations.
  • concentrations in containers 1 - 5 are as follows 0.5 milliMole/L, 2.5 milliMole/L, 10.0 milliMole/L, 25.0 milliMole/L & 50.0 milliMole/L respectively.
  • the containers 12, containing the reagents and the urine samples are preferably incubated in an incubator 14 at a temperature of 37 degrees Centigrade for a duration of about 30 minutes. Thereafter a drop from each of the containers is placed on a slide 16 which is placed under a microscope 18 which is equipped with a video camera 20 .
  • the output of the video camera 20 is supplied to a computer 22 , such as a PC which is equipped with suitable image analysis software, such as Matrox Inspector software, commercially available from Matrox Electronic Systems Ltd. of Dorval, Quebec, Canada together with special purpose software, preferably that presented in Appendix A.
  • a computer 22 such as a PC which is equipped with suitable image analysis software, such as Matrox Inspector software, commercially available from Matrox Electronic Systems Ltd. of Dorval, Quebec, Canada together with special purpose software, preferably that presented in Appendix A.
  • An image analysis output preferably indicating the propensity of a subject to formation of urinary stones, may be provided on a display 24 or in hard copy form 26 by using a printer 28 .
  • FIG. 2 is an illustration of a typical image analysis report provided by the system and method of FIGS. 1 and 3.
  • the report of FIG. 2 preferably includes an image 40 showing calcium oxalate crystals as viewed by the video camera 20 (FIG. 1) together with tabular information 42 relating to the area, brightness, perimeter, compactness, number of holes and roughness of the crystals at various times. Also preferably included in the report of FIG. 2 are graphs which indicate the time variation of various ones of the above parameters. The foregoing information may then be used to arrive at an indication of the propensity of a subject to formation of urinary stones.
  • the software of the present invention may itself provide an indication of the effectiveness of inhibition of crystallization of calcium oxalate salts in the examined urine, as shown at reference numeral 44 .
  • FIG. 4 is a generalized flowchart illustrating the image analysis carried out by the present invention.
  • a video image is acquired of a first portion of a centrifuged urine sample containing a first crystallization inducing reagent following incubation at time T 1 .
  • the first crystallization inducing reagent is the lowest concentration reagent.
  • the brightness level of the acquired video image is normalized and a determination is made as to whether any calcium oxalate crystals are present in the first portion at time T 1 .
  • This procedure is repeated at times T 3 , T 4 . . . TN, where N preferably is equal to 7, each time preferably being separated from the preceding time by approximately 5 minutes.
  • a report preferably containing the content appearing in FIG. 2, is prepared for the portion in which calcium oxalate crystals are encountered.
  • FIG. 5 illustrates the methodology of determination of the presence of calcium oxalate crystals in a portion, in the technique of FIG. 4.
  • FIG. 6 illustrates the methodology of preparing a report such as the report illustrated in FIG. 2.
  • each of the following parameters is averaged over all of the crystals in the video image of a portion at time TN:
  • a numerical and graphical output display showing the variation of the average of each parameter over times from T 1 to TN is prepared.
  • step b) Install the Matrox Inspector 2.1 software described hereinabove on the computer terminal provided in step a) in a directory named ⁇ Insptr;
  • any of the software components of the present invention may, if desired, be implemented in ROM (read-only memory) form.
  • the software components may, generally, be implemented in hardware, if desired, using conventional techniques.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

Apparatus for indicating the propensity of a subject to formation of urinary stones comprising apparatus for optically observing a urine sample from a subject under magnification and an image analyzer operative to determine the existence of crystalline bodies in the urine sample and to provide an output indication thereof.

Description

    FIELD OF THE INVENTION
  • The present invention relates to determination of the propensity of a subject to formation of urinary stones. [0001]
    • BACKGROUND OF THE INVENTION
  • It is estimated that approximately four percent of the adult population, worldwide, encounters a urinary stone difficulty. [0002]
  • Prophylactic treatment is known for preventing the occurrence of urinary stones. What is lacking is an efficient and cost-effective technique for screening the population in order to indicate those persons requiring prophylactic treatment. [0003]
  • Various techniques have been proposed for determining the propensity of a subject to formation of urinary stones. The following U.S. patents are considered to represent the state of the art: U.S. Pat. Nos. 4,025,307; 4,183,729; 4,263,010; 4,399,003; 4,888,182 & 5,064,765. [0004]
    • SUMMARY OF THE INVENTION
  • The present invention seeks to provide an efficient and cost-effective technique and system for indicating the propensity of a subject to formation of urinary stones. [0005]
  • There is thus provided in accordance with a preferred embodiment of the present invention apparatus for indicating the propensity of a subject to formation of urinary stones including apparatus for optically observing a urine sample from a subject under magnification and an image analyzer operative to determine the existence of crystalline bodies in said urine sample and to provide an output indication thereof. [0006]
  • There is also provided in accordance with a preferred embodiment of the present invention apparatus for analyzing urine of a subject including: [0007]
  • apparatus for optically observing a urine sample from a subject under magnification; and [0008]
  • an image analyzer operative to determine the existence of bodies in the urine sample and to provide an output indication thereof. [0009]
  • The bodies may include at least one of cells, crystalline bodies, microorganisms and casts. [0010]
  • Preferably, the image analyzer is also operative to provide an indication of the size of the crystalline bodies. [0011]
  • In accordance with a preferred embodiment of the present invention, the apparatus for optically observing is operative to observe at least one urine sample in the presence of at least one reagent. [0012]
  • Preferably, the apparatus for optically observing a urine sample is operative to observe a plurality of urine samples from a subject in the presence of a plurality of different reagents. [0013]
  • In accordance with a preferred embodiment of the present invention, the plurality of different reagents comprise crystallization inducers of different activities. [0014]
  • Preferably, the plurality of different reagents comprise crystallization inducers of different concentrations. [0015]
  • In accordance with a preferred embodiment of the present invention, the at least one reagent comprises a crystallization inducer. [0016]
  • In accordance with a preferred embodiment of the present invention, the image analyzer includes software which measures the mass of the bodies. [0017]
  • Additionally or alternatively, in accordance with a preferred embodiment of the present invention, the image analyzer includes software which indicates the shape of the bodies. [0018]
  • Additionally or alternatively, in accordance with a preferred embodiment of the present invention, the image analyzer includes software which indicates changes in the bodies over time. [0019]
  • There is also provided in accordance with a preferred embodiment of the present invention a method for indicating the propensity of a subject to formation of urinary stones comprising: [0020]
  • optically observing a urine sample from a subject under magnification; and [0021]
  • performing computerized image analysis to determine the existence of crystalline bodies in the urine sample and to provide an output indication thereof. [0022]
  • There is additionally provided in accordance with a preferred embodiment of the present invention a method for analyzing urine of a subject comprising: [0023]
  • optically observing a urine sample from a subject under magnification; and [0024]
  • performing image analysis to determine the existence of bodies in the urine sample and to provide an output indication thereof.[0025]
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • The present invention will be more fully appreciated from the following detailed description in which: [0026]
  • FIG. 1 is a simplified pictorial illustration of a system and method for analyzing urine of a subject which is particularly useful for indicating the propensity of a subject to formation of urinary stones in accordance with a preferred embodiment of the present invention; [0027]
  • FIG. 2 is an illustration of a typical image analysis report provided by the system and method of FIG. 1; [0028]
  • FIG. 3 is a simplified flowchart illustrating principal functional features of image analysis performed by the system and method of FIG. 1; and [0029]
  • FIGS. 4, 5, and [0030] 6 are each simplified flowcharts illustrating constituents of the functional features of the flowchart of FIG. 3.
    • BRIEF DESCRIPTION OF APPENDIX
  • Appendix A is a hexadecimal dump of software employed in accordance with a preferred embodiment of the present invention. [0031]
    • DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT
  • Reference is now made to FIGS. 1 and 3, which are respectively a simplified pictorial illustration and a flow chart of a system and method for analyzing urine of a subject which is particularly useful for indicating the propensity of a subject to formation of urinary stones in accordance with a preferred embodiment of the present invention. [0032]
  • The present invention, illustrated generally in FIGS. 1 and 3, seeks to provide an efficient and cost-effective technique and system for indicating the propensity of a subject to formation of urinary stones. As seen in FIG. 1, a sample of [0033] urine 10 received from a subject is centrifuged in a centrifuge 11 and thereafter preferably added dropwise to a plurality of containers 12, here numbered 1-5, each containing a reagent which enhances crystallization of calcium oxalate salts in the urine.
  • In accordance with a preferred embodiment of the present invention, the reagent comprises natrium-oxalate in different concentrations. Typically, the concentrations in containers [0034] 1-5 are as follows 0.5 milliMole/L, 2.5 milliMole/L, 10.0 milliMole/L, 25.0 milliMole/L & 50.0 milliMole/L respectively.
  • The [0035] containers 12, containing the reagents and the urine samples are preferably incubated in an incubator 14 at a temperature of 37 degrees Centigrade for a duration of about 30 minutes. Thereafter a drop from each of the containers is placed on a slide 16 which is placed under a microscope 18 which is equipped with a video camera 20.
  • The output of the [0036] video camera 20 is supplied to a computer 22, such as a PC which is equipped with suitable image analysis software, such as Matrox Inspector software, commercially available from Matrox Electronic Systems Ltd. of Dorval, Quebec, Canada together with special purpose software, preferably that presented in Appendix A. An image analysis output, preferably indicating the propensity of a subject to formation of urinary stones, may be provided on a display 24 or in hard copy form 26 by using a printer 28.
  • Reference is now made to FIG. 2 which is an illustration of a typical image analysis report provided by the system and method of FIGS. 1 and 3. The report of FIG. 2 preferably includes an [0037] image 40 showing calcium oxalate crystals as viewed by the video camera 20 (FIG. 1) together with tabular information 42 relating to the area, brightness, perimeter, compactness, number of holes and roughness of the crystals at various times. Also preferably included in the report of FIG. 2 are graphs which indicate the time variation of various ones of the above parameters. The foregoing information may then be used to arrive at an indication of the propensity of a subject to formation of urinary stones. Preferably, the software of the present invention may itself provide an indication of the effectiveness of inhibition of crystallization of calcium oxalate salts in the examined urine, as shown at reference numeral 44.
  • Reference is now made to FIG. 4, which is a generalized flowchart illustrating the image analysis carried out by the present invention. As seen in FIG. 4, a video image is acquired of a first portion of a centrifuged urine sample containing a first crystallization inducing reagent following incubation at time T[0038] 1. Preferably, the first crystallization inducing reagent is the lowest concentration reagent.
  • The brightness level of the acquired video image is normalized and a determination is made as to whether any calcium oxalate crystals are present in the first portion at time T[0039] 1.
  • If no calcium oxalate crystals are present in the first portion at time T[0040] 1, the above procedure is carried out for each of the subsequent portions, containing reagents at increasing concentrations, until a portion containing such crystals is encountered. If no portion containing calcium oxalate crystals is encountered, a report is prepared indicating effectiveness of inhibition of crystallization of calcium oxalate salts in the examined urine.
  • If however, calcium oxalate crystals are found in a portion at time T[0041] 1, the following parameters are recorded for each crystal:
  • AREA [0042]
  • PERIMETER [0043]
  • COMPACTNESS [0044]
  • NUMBER OF HOLES [0045]
  • ROUGHNESS [0046]
  • LENGTH [0047]
  • BREADTH [0048]
  • BRIGHTNESS [0049]
  • Thereafter, at time T[0050] 2, typically 5 minutes following time T1, the above parameters are again recorded for each crystal which was present and inspected at time T1.
  • This procedure is repeated at times T[0051] 3, T4 . . . TN, where N preferably is equal to 7, each time preferably being separated from the preceding time by approximately 5 minutes.
  • A report, preferably containing the content appearing in FIG. 2, is prepared for the portion in which calcium oxalate crystals are encountered. [0052]
  • Reference is now made to FIG. 5, which illustrates the methodology of determination of the presence of calcium oxalate crystals in a portion, in the technique of FIG. 4. [0053]
  • As seen in FIG. 5, there is provided selection of bright regions in the video image which meet all of the following criteria: [0054]
    BREADTH:   3-20 BREADTH UNITS
    COMPACTNESS: 1.5-2.9 COMPACTNESS UNITS
    NUMBER OF HOLES: 0
    ROUGHNESS: 1.1-1.35 ROUGHNESS UNITS
    AREA:  45-125 PIXELS
  • All bright regions fulfilling the above criteria are identified as calcium oxalate crystals. [0055]
  • Reference is now made to FIG. 6, which illustrates the methodology of preparing a report such as the report illustrated in FIG. 2. [0056]
  • As indicated in FIG. 6, each of the following parameters is averaged over all of the crystals in the video image of a portion at time TN: [0057]
  • AREA [0058]
  • PERIMETER [0059]
  • COMPACTNESS [0060]
  • NUMBER OF HOLES [0061]
  • ROUGHNESS [0062]
  • LENGTH [0063]
  • BREADTH [0064]
  • BRIGHTNESS [0065]
  • A numerical and graphical output display showing the variation of the average of each parameter over times from T[0066] 1 to TN is prepared.
  • As indicated above, if no portion containing calcium oxalate crystals is encountered, a report is prepared indicating effectiveness of inhibition of crystallization of calcium oxalate salts in the examined urine. [0067]
  • If calcium oxalate crystals are found in the first portion, a report is prepared indicating ineffective inhibition of crystallization of calcium oxalate salts in the examined urine. [0068]
  • If, however, crystals are not found in the first portion and only one crystal is found in fourth or fifth portion, a report is prepared indicating effective inhibition of crystallization of calcium oxalate salts in the examined urine. [0069]
  • Should crystals not be found in the first portion and more than one crystal be found in the fourth or fifth portion or at least one crystal be found in the second or third portion, and growth of at least five percent be found in the crystals over time T[0070] 1−TN, a report is prepared indicating ineffective inhibition of crystallization of calcium oxalate salts in the examined urine.
  • A preferred method for constructing a system for indicating the propensity of a subject to formation of urinary stones operative in accordance with a preferred embodiment of the present invention is now described with reference to Appendix A: [0071]
  • a) Provide a computer terminal configured with the Microsoft Windows 95 operating system; [0072]
  • b) Install the Matrox Inspector 2.1 software described hereinabove on the computer terminal provided in step a) in a directory named \Insptr; [0073]
  • c) Generate the binary file TmpDll.dll from the portion of the hexadecimal software listing of Appendix A labeled “hex_code.txt”, and the binary file ProjectNew.scr and from the portion labeled “ProjectNew.scr”; [0074]
  • d) Load the files generated in step c) into a subdirectory of \Insptr named \Project; [0075]
  • e) Execute the program Insptr32.exe in the \Insptr directory and double-click on the last available project icon. [0076]
  • It is appreciated that any of the software components of the present invention may, if desired, be implemented in ROM (read-only memory) form. The software components may, generally, be implemented in hardware, if desired, using conventional techniques. [0077]
  • It is appreciated that the particular embodiment described in Appendix A is intended only to provide an extremely detailed disclosure of the present invention and is not intended to be limiting. [0078]
  • It will be appreciated by persons skilled in the art that the present invention is not limited to what has been specifically shown and described hereinabove. Rather the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove as well as modifications thereof which would occur to persons skilled in the art upon reading the foregoing description and which are not in the prior art. [0079]

Claims (40)

1. Apparatus for indicating the propensity of a subject to formation of urinary stones comprising:
apparatus for optically observing a urine sample from a subject under magnification; and
an image analyzer operative to determine the existence of crystalline bodies in said urine sample and to provide an output indication thereof.
2. Apparatus for indicating the propensity of a subject to formation of urinary stones according to claim 1 and wherein said image analyzer is also operative to provide an indication of the size of said crystalline bodies.
3. Apparatus for indicating the propensity of a subject to formation of urinary stones according to claim 1 and wherein said apparatus for optically observing a urine sample is operative to observe at least one urine sample in the presence of at least one reagent.
4. Apparatus for indicating the propensity of a subject to formation of urinary stones according to claim 3 and wherein said apparatus for optically observing a urine sample is operative to observe a plurality of urine samples from a subject in the presence of a plurality of different reagents.
5. Apparatus for indicating the propensity of a subject to formation of urinary stones according to claim 4 and wherein said plurality of different reagents comprise crystallization inducers of different activities.
6. Apparatus for indicating the propensity of a subject to formation of urinary stones according to claim 4 and wherein said plurality of different reagents comprise crystallization inducers of different concentrations.
7. Apparatus for indicating the propensity of a subject to formation of urinary stones according to claim 3 and wherein said at least one reagent comprises a crystallization inducer.
8. Apparatus for indicating the propensity of a subject to formation of urinary stones according to claim 1 and wherein said image analyzer includes software which measures the mass of said crystalline bodies.
9. Apparatus for indicating the propensity of a subject to formation of urinary stones according to claim 1 and wherein said image analyzer includes software which indicates the shape of said crystalline bodies.
10. Apparatus for indicating the propensity of a subject to formation of urinary stones according to claim 1 and wherein said image analyzer includes software which indicates changes in said crystalline bodies over time.
11. Apparatus for analyzing urine of a subject comprising:
apparatus for optically observing a urine sample from a subject under magnification; and
an image analyzer operative to determine the existence of bodies in surine sample and to provide an output indication thereof.
12. Apparatus for analyzing the urine of a subject according to claim 11 and wherein said image analyzer is also operative to provide an indication of the size of said bodies.
13. Apparatus for analyzing the urine of a subject according to claim 11 and wherein said apparatus for optically observing a urine sample is operative to observe at least one urine sample in the presence of at least one reagent.
14. Apparatus for analyzing the urine of a subject according to claim 13 and wherein said apparatus for optically observing a urine sample is operative to observe a plurality of urine samples from a subject in the presence of a plurality of different reagents.
15. Apparatus for analyzing the urine of a subject according to claim 14 and wherein said plurality of different reagents comprise reagents of different activities.
16. Apparatus for analyzing the urine of a subject according to claim 14 and wherein said plurality of different reagents comprise reagents of different concentrations.
17. Apparatus for analyzing the urine of a subject according to claim 13 and wherein said bodies include at least one of cells, crystalline bodies, microorganisms and casts.
18. Apparatus for analyzing the urine of a subject according to claim 11 and wherein said image analyzer includes software which measures the mass of said bodies.
19. Apparatus for analyzing the urine of a subject according to claim 11 and wherein said image analyzer includes software which indicates the shape of said bodies.
20. Apparatus for analyzing the urine of a subject according to claim 11 and wherein said image analyzer includes software which indicates changes in said bodies over time.
21. A method for indicating the propensity of a subject to formation of urinary stones comprising:
optically observing a urine sample from a subject under magnification; and
performing computerized image analysis to determine the existence of crystalline bodies in said urine sample and to provide an output indication thereof.
22. A method for indicating the propensity of a subject to formation of urinary stones according to claim 21 and wherein said image analysis is also operative to provide an indication of the size of said crystalline bodies.
23. A method for indicating the propensity of a subject to formation of urinary stones according to claim 21 and wherein said step of optically observing a urine sample is operative to observe at least one urine sample in the presence of at least one reagent.
24. A method for indicating the propensity of a subject to formation of urinary stones according to claim 3 and wherein said step of optically observing a-urine sample is operative to observe a plurality of urine samples from a subject in the presence of a plurality of different reagents.
25. A method for indicating the propensity of a subject to formation of urinary stones according to claim 24 and wherein said plurality of different reagents comprise crystallization inducers of different activities.
26. A method for indicating the propensity of a subject to formation of urinary stones according to claim 24 and wherein said plurality of different reagents comprise crystallization inducers of different concentrations.
27. A method for indicating the propensity of a subject to formation of urinary stones according to claim 23 and wherein said at least one reagent comprises a crystallization inducer.
28. A method for indicating the propensity of a subject to formation of urinary stones according to claim 21 and wherein said image analysis measures the mass of said crystalline bodies.
29. A method for indicating the propensity of a subject to formation of urinary stones according to claim 21 and wherein said image analysis indicates the shape of said crystalline bodies.
30. A method for indicating the propensity of a subject to formation of urinary stones according to claim 21 and wherein said image analysis indicates changes in said crystalline bodies over time.
31. A method for analyzing urine of a subject comprising:
optically observing a urine sample from a subject under magnification; and
performing image analysis to determine the existence of bodies in said urine sample and to provide an output indication thereof.
32. A method for analyzing the urine of a subject according to claim 31 and wherein said image analysis is also operative to provide an indication of the size of said bodies.
33. A method for analyzing the urine of a subject and wherein said step of optically observing a urine sample is operative to observe at least one urine sample in the presence of at least one reagent.
34. A method for analyzing the urine of a subject according to claim 33 and wherein said apparatus for optically observing a urine sample is operative to observe a plurality of urine samples from a subject in the presence of a plurality of different reagents.
35. A method for analyzing the urine of a subject according to claim 34 and wherein said plurality of different reagents comprise reagents of different activities.
36. A method for analyzing the urine of a subject according to claim 34 and wherein said plurality of different reagents comprise reagents of different concentrations.
37. A method for analyzing the urine of a subject according to claim 33 and wherein said bodies include at least one of cells, crystalline bodies, microorganisms and casts.
38. A method for analyzing the urine of a subject according to claim 31 and wherein said image analysis measures the mass of said bodies.
39. A method for analyzing the urine of a subject according to claim 31 and wherein said image analysis indicates the shape of said bodies.
40. A method for analyzing the urine of a subject according to claim 31 and wherein said image analysis indicates changes in said bodies over time.
US10/027,522 1998-11-04 2001-12-20 Image analysis of urine Abandoned US20020081743A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/027,522 US20020081743A1 (en) 1998-11-04 2001-12-20 Image analysis of urine

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL126881 1998-11-04
IL12688198A IL126881A0 (en) 1998-11-04 1998-11-04 Image analysis of urine
US09/232,528 US6391644B1 (en) 1998-11-04 1999-01-18 Image analysis of urine
US10/027,522 US20020081743A1 (en) 1998-11-04 2001-12-20 Image analysis of urine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/232,528 Continuation US6391644B1 (en) 1998-11-04 1999-01-18 Image analysis of urine

Publications (1)

Publication Number Publication Date
US20020081743A1 true US20020081743A1 (en) 2002-06-27

Family

ID=11072100

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/232,528 Expired - Fee Related US6391644B1 (en) 1998-11-04 1999-01-18 Image analysis of urine
US10/027,522 Abandoned US20020081743A1 (en) 1998-11-04 2001-12-20 Image analysis of urine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/232,528 Expired - Fee Related US6391644B1 (en) 1998-11-04 1999-01-18 Image analysis of urine

Country Status (3)

Country Link
US (2) US6391644B1 (en)
IL (1) IL126881A0 (en)
JO (1) JO2086B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020514716A (en) * 2016-12-27 2020-05-21 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド Calcium oxalate titration test kit and pet food composition

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013022253A1 (en) * 2013-12-31 2015-07-02 NTTF Coatings GmbH Apparatus and method for determining the likelihood of crystallization of a salt in a liquid ion-containing sample

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025307A (en) 1976-01-23 1977-05-24 University Patents, Inc. Method and apparatus for determining crystallization properties of urine
US4183729A (en) 1978-02-27 1980-01-15 University Patents, Inc. Apparatus and method for determining crystallization properties of urine
US4263010A (en) 1979-10-31 1981-04-21 University Patents, Inc. Control method and apparatus for crystallizer process control
IL59982A (en) 1980-05-02 1982-12-31 Yissum Res Dev Co Method and kit for diagnosing a patient's proneness to develop calcium oxalate kidney stones
US4888182A (en) 1983-04-11 1989-12-19 Board Of Regents Of The University Of Texas System Compositions and methods of treating calcium renal stones
IL89447A0 (en) 1989-03-02 1989-09-10 Galai Lab Ltd Analytical clinical method and device for carrying out such method
US5122284A (en) * 1990-06-04 1992-06-16 Abaxis, Inc. Apparatus and method for optically analyzing biological fluids
JP3098273B2 (en) * 1991-05-14 2000-10-16 シスメックス株式会社 Urine cell analyzer
US5733721A (en) * 1992-11-20 1998-03-31 The Board Of Regents Of The University Of Oklahoma Cell analysis method using quantitative fluorescence image analysis
ES2278566T3 (en) * 1994-10-20 2007-08-16 Sysmex Corporation REAGENT AND METHOD FOR ANALYZING SOLID COMPONENTS IN THE URINE.
US6004821A (en) * 1998-03-07 1999-12-21 Levine; Robert A. Method and apparatus for performing chemical, qualitative, quantitative, and semi-quantitative analyses of a urine sample

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020514716A (en) * 2016-12-27 2020-05-21 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド Calcium oxalate titration test kit and pet food composition
US11330830B2 (en) 2016-12-27 2022-05-17 Hills Pet Nutrition, Inc. Calcium oxalate titration test kits and pet food compositions

Also Published As

Publication number Publication date
JO2086B1 (en) 2000-05-21
US6391644B1 (en) 2002-05-21
IL126881A0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
ATE155820T1 (en) TEST FOR PREDICTING THE OUTCOME OF IVF
Klee Clinical interpretation of reference intervals and reference limits. A plea for assay harmonization
Cairns Jr et al. Problems associated with selecting the most sensitive species for toxicity testing
WO2003052409A1 (en) Water monitoring method using algae
Favaloro et al. Testing for the lupus anticoagulant: the good, the bad, and the ugly
Kemppainen et al. Measurement of total thyroxine concentration in serum from dogs and cats by use of various methods
MILOS et al. Evaluation and performance characteristics of the coagulation system: ACL TOP analyzer–HemosIL reagents
Kobilinsky et al. Minimum cost acceptance sampling plans for grain control, with application to GMO detection
US6391644B1 (en) Image analysis of urine
US20080261254A1 (en) Procedure for the determination of the reaction lag phase in an analyte-dependent reaction
Kolesnik et al. Image analysis system for quantitative immunofluorescence measurement
Benson et al. Optimal discrimination of mild hyperparathyroidism with total serum calcium, ionized calcium and parathyroid hormone measurements
Smith et al. Biological variation of biochemical analytes determined at 8‐week intervals for 1 year in clinically healthy cats
Manley et al. Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at-20 degrees C
Chieng et al. Comparison of quantitative polymerase chain reaction, Kato-Katz and circulating cathodic antigen rapid test for the diagnosis of Schistosoma mansoni infection: A cross-sectional study in Kirinyaga County, Kenya
Wada et al. Analytical goals for coagulation tests based on biological variation.
Hirschowitz et al. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia
Witting et al. Evaluation of a new specific analysis of urinary delta-aminolevulinic acid in man
Knight Quality assessment of a prenatal screening program
McEvoy et al. Nortestosterone is not a naturally occurring compound in male cattle.
JP2922295B2 (en) Sublethal bioassay for environmental quality
Jansen The quest for comparability: Calibration 2000
Lum et al. Clinical assessment of the electrophoretic separation of alkaline phosphatase isoenzymes
RU2722758C1 (en) Set of synthetic oligonucleotides for detecting dnas of representatives of deer family
Lanevschi et al. Comparison of two dry chemistry analyzers and a wet chemistry analyzer using canine serum

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION